Announce Date | 05/06/2025 |
EPS Normalized Actual | $-0.78 (Miss by $-0.07) |
EPS GAAP Actual | $-0.78 (Miss by $-0.07) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.61 |
EPS GAAP Estimate | $-0.61 |
Revenue Estimate | $0.025B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 0.67215 | 21.84 | -0.04799509 | 1.6555 | 3 |
Dec 2028 | 0.44667 | 32.87 | 0.06062455 | 1.33567 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.78 | -0.04 | 0B | NAN% | -25M |
FQ4 2024 (Dec 2024) | -0.67 | 0.00722 | 0B | NAN% | -13.67M |
FQ3 2024 (Sep 2024) | -0.63 | 0.04518 | 0B | -INF% | -15.86M |
FQ1 2016 (Mar 2016) | -3.37 | -3.37 | 0B | NAN% | 0M |
FQ2 2016 (Jun 2016) | -3.37 | -3.37 | 0B | NAN% | 0M |
FQ3 2016 (Sep 2016) | -4.51 | -4.51 | 0B | NAN% | 0M |
FQ2 2024 (Jun 2024) | -0.59 | -1.93259 | 0B | -INF% | -2.22M |
FQ1 2024 (Mar 2024) | -0.68 | -0.68 | 0B | -INF% | 0M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.61
Consensus Revenue Estimates
0.025B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | -0.7638 | -- | -0.7638 | -0.7638 | 1 |
FQ3 2026 (Sep 2026) | -0.7665 | -- | -0.7665 | -0.7665 | 1 |
FQ2 2026 (Jun 2026) | -0.7762 | -- | -0.7762 | -0.7762 | 1 |
FQ1 2026 (Mar 2026) | -0.7795 | -0.06 | -0.7795 | -0.7795 | 1 |
FQ4 2025 (Oct 2025) | -0.56 | -19.64 | -0.89459 | -0.17975 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.02B | -- | 0.02B | 0.02B | 1 |
FQ3 2026 (Sep 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ2 2026 (Jun 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ1 2026 (Mar 2026) | 0B | -- | 0B | 0B | 1 |
FQ4 2025 (Oct 2025) | 0.03B | -- | 0.01B | 0.04B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
0
Revenue # of Misses
4
Revenue # of in-lines
4
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.74 | -0.78 | -0.04 | 5.13% |
FQ4 2024 (Dec 2024) | -0.67722 | -0.67 | 0.00722 | -1.08% |
FQ3 2024 (Sep 2024) | -0.67518 | -0.63 | 0.04518 | -7.17% |
FQ1 2016 (Mar 2016) | -3.37 | -3.37 | 100% | |
FQ2 2016 (Jun 2016) | -3.37 | -3.37 | 100% | |
FQ3 2016 (Sep 2016) | -4.51 | -4.51 | 100% | |
FQ2 2024 (Jun 2024) | 1.34259 | -0.59 | -1.93259 | 327.56% |
FQ1 2024 (Mar 2024) | -0.68 | -0.68 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.03B | $0B | $-25M | -INF% |
FQ4 2024 (Dec 2024) | $0.01B | $0B | $-13.67M | -INF% |
FQ3 2024 (Sep 2024) | $0.02B | $0B | $-15.86M | -INF% |
FQ1 2016 (Mar 2016) | $0B | $0B | $0M | NAN% |
FQ2 2016 (Jun 2016) | $0B | $0B | $0M | NAN% |
FQ3 2016 (Sep 2016) | $0B | $0B | $0M | NAN% |
FQ2 2024 (Jun 2024) | $0B | $0B | $-2.22M | -INF% |
FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |